Silverfin false false 30/06/2024 01/07/2023 30/06/2024 Dr S Martino 16/06/2022 Dr G Tritto 16/06/2022 25 October 2024 The principal activity of the company during the financial year was that of specialist medical practice activities. 14176817 2024-06-30 14176817 bus:Director1 2024-06-30 14176817 bus:Director2 2024-06-30 14176817 core:CurrentFinancialInstruments 2024-06-30 14176817 core:CurrentFinancialInstruments 2023-06-30 14176817 2023-06-30 14176817 core:ShareCapital 2024-06-30 14176817 core:ShareCapital 2023-06-30 14176817 core:RetainedEarningsAccumulatedLosses 2024-06-30 14176817 core:RetainedEarningsAccumulatedLosses 2023-06-30 14176817 2023-07-01 2024-06-30 14176817 bus:FilletedAccounts 2023-07-01 2024-06-30 14176817 bus:SmallEntities 2023-07-01 2024-06-30 14176817 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 14176817 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 14176817 bus:Director1 2023-07-01 2024-06-30 14176817 bus:Director2 2023-07-01 2024-06-30 14176817 2022-07-01 2023-06-30 iso4217:GBP xbrli:pure

Company No: 14176817 (England and Wales)

GUT & LIVER HEALTH LTD

Unaudited Financial Statements
For the financial year ended 30 June 2024
Pages for filing with the registrar

GUT & LIVER HEALTH LTD

Unaudited Financial Statements

For the financial year ended 30 June 2024

Contents

GUT & LIVER HEALTH LTD

STATEMENT OF FINANCIAL POSITION

As at 30 June 2024
GUT & LIVER HEALTH LTD

STATEMENT OF FINANCIAL POSITION (continued)

As at 30 June 2024
Note 2024 2023
£ £
Current assets
Debtors 3 6,240 250
Cash at bank and in hand 4 47,066 3,416
53,306 3,666
Creditors: amounts falling due within one year 5 ( 11,820) ( 3,513)
Net current assets 41,486 153
Total assets less current liabilities 41,486 153
Net assets 41,486 153
Capital and reserves
Called-up share capital 100 100
Profit and loss account 41,386 53
Total shareholders' funds 41,486 153

For the financial year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Gut & Liver Health Ltd (registered number: 14176817) were approved and authorised for issue by the Board of Directors. They were signed on its behalf by:

Dr S Martino
Director

25 October 2024

GUT & LIVER HEALTH LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 June 2024
GUT & LIVER HEALTH LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 June 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Gut & Liver Health Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the company's registered office is 35 Ballards Lane, London, N3 1XW, England, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

The Company only enters into basic financial instruments and transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to and from related parties and investments in non-puttable ordinary shares.

Financial assets
Basic financial assets, including trade and other debtors, and amounts due from related companies, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Such assets are subsequently carried at amortised cost using the effective interest method.

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in the Statement of Income and Retained Earnings/Statement of Comprehensive Income.

Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or (c) control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions.

Financial liabilities
Basic financial liabilities, including trade and other creditors and accruals, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the company during the year, including directors 2 2

3. Debtors

2024 2023
£ £
Trade debtors 6,240 250

4. Cash and cash equivalents

2024 2023
£ £
Cash at bank and in hand 47,066 3,416

5. Creditors: amounts falling due within one year

2024 2023
£ £
Amounts owed to directors 520 2,000
Accruals 1,500 1,500
Taxation and social security 9,800 13
11,820 3,513